ISRCTN36729271已完成未知
The Zambia, South Africa, Tuberculosis and Acquired Immune Deficiency Syndrome-reduction Trial
Consortium to Respond Effectively to the AIDS-Tuberculosis Epidemic (CREATE) (USA)0 个研究点目标入组 1,500,000 人开始时间: 2006年5月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,500,000
研究概览
简要总结
2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23915882 results 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34907038/ secondary analysis (added 16/12/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Population served by tuberculosis diagnostic centre in each of 24 communities
排除标准
- •Individuals who do not consent to trial procedures
研究者
相似试验
终止
2 期
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIVHIV InfectionPneumocystis Jiroveci PneumoniaTuberculosisNCT00080119International Maternal Pediatric Adolescent AIDS Clinical Trials Group1,354
进行中（未招募）
不适用
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19COVID-19TuberculosisHIV InfectionsNCT05220163University of Cape Town26,200
已完成
3 期
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan AfricaHIV I InfectionTuberculosisSepsisNCT04618198University of Virginia437
已完成
2 期
Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected PeopleTuberculosisHIV InfectionsNCT00052195Dartmouth-Hitchcock Medical Center1,975
已完成
不适用
Evaluation of PTB Screening in ANC in Lusaka, ZambiaPulmonary TuberculosisNCT02053129University of North Carolina, Chapel Hill5,033